Skip to main content
Full access
Letters to the Editor
Published Online: 1 January 2019

Controlled Substances in the Polydrug Epidemic: Response to Diller

To the Editor: The current response to the crisis of opioid overdose deaths and addiction has focused attention not just in medicine, but broadly in the nation, on the primary role of prescribed opioids. Largely unrecognized is the role of other prescribed controlled substances in nonmedical drug use, addiction, and overdose deaths, particularly stimulants and benzodiazepines. Compton et al. (1) and Diller (2) usefully focus on underscoring the role of stimulants. The intertwining of legal and illegal drugs is seen in overdose data from the Florida Drug-Related Outcomes Surveillance and Tracking System (FROST) that show the polydrug nature of overdose deaths (3). Dr. Diller’s suggestion for physicians to refrain from prescribing immediate-release formulations of prescription stimulants to adults is an excellent example of rethinking the important role of medical practice in the growing drug crisis (4).

References

1.
Compton WM, Han B, Blanco C, et al: Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. Am J Psychiatry 2018; 175:741–755
2.
Diller L: Comment on prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. Am J Psychiatry 2019; 176:77
3.
DuPont RL: A new narrative to understand the opioid epidemic. J Glob Drug Policy Pract 2018; 12
4.
Arria AM, DuPont RL: Prescription stimulant use and misuse: implications for responsible prescribing practices. Am J Psychiatry 2018; 175:707–708

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 78
PubMed: 30848950

History

Accepted: 9 October 2018
Published online: 1 January 2019
Published in print: January 01, 2019

Keywords

  1. Stimulant Abuse
  2. ADHD
  3. CNS Stimulants
  4. Epidemiology
  5. Psychoactive Substance Use Disorder

Authors

Affiliations

Robert L. DuPont, M.D. [email protected]
Institute for Behavior and Health, Rockville, Md. (DuPont); Center on Young Adult Health and Development, Department of Behavioral and Community Health, University of Maryland School of Public Health, College Park (Arria).
Amelia M. Arria, Ph.D.
Institute for Behavior and Health, Rockville, Md. (DuPont); Center on Young Adult Health and Development, Department of Behavioral and Community Health, University of Maryland School of Public Health, College Park (Arria).

Notes

Send correspondence to Dr. DuPont ([email protected]).

Funding Information

Supported by NIDA grant U01DA040219.The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share